Neuromodulation device supporting treatment of cognitive decline conditions including Alzheimer's Disease through enhanced neuroplasticity and cognitive enhancement.
Manufactured by
Warszawa, Poland
QVITI is a Polish neurotech/medtech company that has been developing technologies based on transcranial electrical stimulation (tES) and AI-enhanced immersive VR therapies since 2018. By leveraging the mechanisms of neuroplasticity, QVITI s solutions are applied not only in medical contexts but also in high-performance and high-stress environments , including the defense and security sectors , to enhance focus, cognitive resilience, recovery, and decision-making efficiency . In the medical field, QVITI s technologies bring measurable improvement to patients suffering from chronic pain, phantom pain, depression, and PTSD , while also accelerating neurological rehabilitation after stroke . The same neuroplasticity-driven mechanisms that support recovery can also be applied to neuro-enhancement —improving attention, stress resilience, training efficiency, and cognitive recovery in military and demanding operational settings. QVITI s solutions are already used across four continents , in clinics, research centers, and home therapy environments . The company collaborates with world-leading institutions such as Mount Sinai Hospital , Shirley Ryan AbilityLab , and Harvard Medical School , and its innovations are protected by an international patent portfolio . The flagship device, Corstim tES , provides safe, age-independent therapy for neurological rehabilitation, mental health support, and pain management .
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
BioPro Scientific Co., Ltd.
Taiwan · 3 relevant products
Remed Co., Ltd
South Korea · 3 relevant products
Qinhuangdao Huisianpu Medical Systems Inc.
China · 1 relevant product
Harbin Aobo Medical Apparatus Co.,Ltd
China · 9 relevant products
HEMEX AG
Switzerland · 2 relevant products
AT&C CO.,LTD.
South Korea · 2 relevant products
SHANGHAI SHAONAO SENSING TECHNOLOGY CO.,LTD.
China · 2 relevant products
Verge HealthTech Fund
Singapore · 1 relevant product
Emocog Inc.
South Korea · 2 relevant products
BTL Medical Equipment Trading LLC
United Arab Emirates · 1 relevant product
26 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 61 closest product alternatives
BioPro Scientific Co., Ltd. · Taiwan
Precision cranial electrical stimulation system with arbitrary waveform generation and biomarker-based trigger capability. Designed for mood disorder and cognitive dysfunction management.
Remed Co., Ltd · South Korea
Electronic therapeutic device for neurological treatment and brain disorder management.
Qinhuangdao Huisianpu Medical Systems Inc. · China
Comprehensive cognitive health management equipment for full-chain assessment and intervention in neurodegenerative disease prevention.
Remed Co., Ltd · South Korea
Advanced electronic therapy system for psychiatry and neurology applications. Delivers precision stimulation for neurological disorder management. Clinical-grade device for hospital and specialized medical facilities.
Harbin Aobo Medical Apparatus Co.,Ltd · China
A therapeutic device designed for Alzheimer's disease treatment and symptom management. It is included in the company's medical product line.
HEMEX AG · Switzerland
Non-invasive, home-based neuromodulation device for treating early to moderate Alzheimer's disease through personalized electrical stimulation targeting glial cells. Enables patient self-administration in home setting.
AT&C CO.,LTD. · South Korea
A dementia treatment system that combines Transcranial Magnetic Stimulation (TMS) electronic medicine technology with digital therapeutics cognitive learning programs. It is the first treatment device in Korea that integrates an electromagnetic stimulator with a dementia learning program by applying proprietary artificial intelligence image analysis and robot control technology. The device is currently undergoing confirmatory clinical trials.
Harbin Aobo Medical Apparatus Co.,Ltd · China
Transcranial magnetic-electric stimulation device for treating mild to moderate Alzheimer's disease and other neurodegenerative conditions. Combines permanent magnet, low-voltage electrical stimulation, and audio signals to modulate neural activity and promote cognitive recovery. Indicated for use in neurology, rehabilitation, and geriatric care settings.
SHANGHAI SHAONAO SENSING TECHNOLOGY CO.,LTD. · China
This device incorporates SSVEP brain-computer interface technology with neural feedback mechanisms to collect, process, and provide feedback on patient brain electrical activity. It helps patients gain insight into their attention state, prevent cognitive decline, and provide new pathways for alleviating dementia symptoms.
Verge HealthTech Fund · Singapore
Innovative therapeutic technology designed to enhance the brain's natural cleaning system for improved neurological function. The device targets neurodegenerative processes through biological optimization.
Emocog Inc. · South Korea
A digital therapeutic device for mild cognitive impairment (MCI) patients designed to delay cognitive function deterioration. The software periodically monitors individual patient cognitive status and provides customized cognitive training. Designated as Innovative Medical Device No. 35 (Advanced Technology Category) and is the first domestic cognitive intervention therapy software targeting MCI. Features a voice conversation-based interface for patient comfort, adjusts difficulty levels according to training achievement, and can be used in daily life alongside medical consultation and prescription.
HEMEX AG · Switzerland
Non-invasive, home-based neuromodulation device targeting glial cells with personalized electrical stimulation for early to moderate-stage Alzheimer's disease treatment.
49 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products